ロード中...

The Evaluation of Drug Delivery Nanocarrier Development and Pharmacological Briefing for Metabolic-Associated Fatty Liver Disease (MAFLD): An Update

Current research indicates that the next silent epidemic will be linked to chronic liver diseases, specifically non-alcoholic fatty liver disease (NAFLD), which was renamed as metabolic-associated fatty liver disease (MAFLD) in 2020. Globally, MAFLD mortality is on the rise. The etiology of MAFLD is...

詳細記述

保存先:
書誌詳細
出版年:Pharmaceuticals (Basel)
主要な著者: Abou Assi, Reem, Abdulbaqi, Ibrahim M., Siok Yee, Chan
フォーマット: Artigo
言語:Inglês
出版事項: MDPI 2021
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC8001129/
https://ncbi.nlm.nih.gov/pubmed/33806527
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ph14030215
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!